| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| b' Richard James Huntsman, Richard Tang-Wai, Bryan Acton, Jane Alcorn, Andrew William Lyon, Darrell David Mousseau, Blair Seifert, Robert Laprairie, Erin Prosser-Loose, Lumir Ondrej Hanu\\xc5\\xa. Cannabis for the treatment of paediatric epilepsy? An update for Canadian paediatricians. Paediatrics & child health. vol 23. issue 6. 2020-09-30. PMID:30455572.' |
cannabis for the treatment of paediatric epilepsy? |
2020-09-30 |
2023-08-13 |
Not clear |
| Guido Fanelli, Giuliano De Carolis, Claudio Leonardi, Adele Longobardi, Ennio Sarli, Massimo Allegri, Michael E Schatma. Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patients. Journal of pain research. vol 10. 2020-09-29. PMID:28579820. |
in 2015, the italian government authorized the use of cannabis to treat several diseases, including chronic pain generally, spasticity in multiple sclerosis, cachexia and anorexia among aids and cancer patients, glaucoma, tourette syndrome, and certain types of epilepsy. |
2020-09-29 |
2023-08-13 |
Not clear |
| M Scott Perr. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy. Epilepsy currents. vol 19. issue 2. 2020-09-28. PMID:30955420. |
don't fear the reefer-evidence mounts for plant-based cannabidiol as treatment for epilepsy. |
2020-09-28 |
2023-08-13 |
Not clear |
| Yasmeen M Taalab, Wessam Fathi Mohammed, Manar A Helmy, Alyaa A A Othman, Mohamed Darwish, Ibrahim Hassan, Mohammed Abba. Cannabis Influences the Putative Cytokines-Related Pathway of Epilepsy among Egyptian Epileptic Patients. Brain sciences. vol 9. issue 12. 2020-09-28. PMID:31757102. |
cannabis influences the putative cytokines-related pathway of epilepsy among egyptian epileptic patients. |
2020-09-28 |
2023-08-13 |
Not clear |
| Yasmeen M Taalab, Wessam Fathi Mohammed, Manar A Helmy, Alyaa A A Othman, Mohamed Darwish, Ibrahim Hassan, Mohammed Abba. Cannabis Influences the Putative Cytokines-Related Pathway of Epilepsy among Egyptian Epileptic Patients. Brain sciences. vol 9. issue 12. 2020-09-28. PMID:31757102. |
the study aims to investigate: (1) the prevalence of cannabis among epileptic patients seen at mansoura university hospital, (2) serum levels and gene expression of cytokines in epilepsy patients and the controls. |
2020-09-28 |
2023-08-13 |
Not clear |
| Yasmeen M Taalab, Wessam Fathi Mohammed, Manar A Helmy, Alyaa A A Othman, Mohamed Darwish, Ibrahim Hassan, Mohammed Abba. Cannabis Influences the Putative Cytokines-Related Pathway of Epilepsy among Egyptian Epileptic Patients. Brain sciences. vol 9. issue 12. 2020-09-28. PMID:31757102. |
and (3) the possibility that cannabis use affects the cytokine levels in epilepsy patients, triggering its future use in treatment. |
2020-09-28 |
2023-08-13 |
Not clear |
| Bruria Ben-Zee. Medical Cannabis for Intractable Epilepsy in Childhood: A Review. Rambam Maimonides medical journal. vol 11. issue 1. 2020-09-28. PMID:32017679. |
medical cannabis for intractable epilepsy in childhood: a review. |
2020-09-28 |
2023-08-13 |
Not clear |
| Bruria Ben-Zee. Medical Cannabis for Intractable Epilepsy in Childhood: A Review. Rambam Maimonides medical journal. vol 11. issue 1. 2020-09-28. PMID:32017679. |
this paper presents and discusses the current accumulated knowledge regarding artisanal cannabis and epidiolex®, a united states food and drug administration (fda)-approved pure cannabidiol (cbd), in epilepsy management in pediatrics, by reviewing the literature and raising debate regarding further research directions. |
2020-09-28 |
2023-08-13 |
Not clear |
| Adi Aran, Dalit Cayam-Ran. Medical Cannabis in Children. Rambam Maimonides medical journal. vol 11. issue 1. 2020-09-28. PMID:32017680. |
while robust evidence currently exists only for pure cannabidiol (cbd) to treat specific types of refractory epilepsy, in most cases, artisanal strains of cbd-rich medical cannabis are being used to treat children with various types of refractory epilepsy or irritability associated with autism spectrum disorder (asd). |
2020-09-28 |
2023-08-13 |
Not clear |
| Adi Aran, Dalit Cayam-Ran. Medical Cannabis in Children. Rambam Maimonides medical journal. vol 11. issue 1. 2020-09-28. PMID:32017680. |
this review summarizes the current evidence for safety, tolerability, and efficacy of medical cannabis in children with epilepsy and in children with asd. |
2020-09-28 |
2023-08-13 |
Not clear |
| Ayushe A Sharma, Rodolphe Nenert, Jane B Allendorfer, Tyler E Gaston, Leslie P Grayson, Kathleen Hernando, Jerzy P Szaflarsk. A preliminary study of the effects of cannabidiol (CBD) on brain structure in patients with epilepsy. Epilepsy & behavior reports. vol 12. 2020-09-28. PMID:32322816. |
a preliminary study of the effects of cannabidiol (cbd) on brain structure in patients with epilepsy. |
2020-09-28 |
2023-08-13 |
Not clear |
| Yuji Masataka, Ichiro Takumi, Edward Maa, Hitoshi Yamamot. Report of a 6-month-old Asian infant with early infantile epileptic encephalopathy whose seizures were eliminated by cannabidiol. Epilepsy & behavior reports. vol 14. 2020-09-28. PMID:32695984. |
cannabidiol's effectiveness in treating drug-resistant epilepsy has been confirmed in large-scale clinical trials in europe and the united states; however, no such trials have been run in asia. |
2020-09-28 |
2023-08-13 |
Not clear |
| Yuji Masataka, Ichiro Takumi, Edward Maa, Hitoshi Yamamot. Report of a 6-month-old Asian infant with early infantile epileptic encephalopathy whose seizures were eliminated by cannabidiol. Epilepsy & behavior reports. vol 14. 2020-09-28. PMID:32695984. |
this important case suggests that high-dose artisanal cannabidiol may effectively treat drug-resistant epilepsy in patients without access to pharmaceutical-grade cbd. |
2020-09-28 |
2023-08-13 |
Not clear |
| Keri-Ann R Buchanan-Peart, Geraldine I Oribhabor, Rhutuja V Khokale, Maxine L Nelson, Ivan Cancarevi. Cannabis, More Than the Euphoria: Its Therapeutic Use in Drug-Resistant Epilepsy. Cureus. vol 12. issue 7. 2020-09-28. PMID:32832296. |
cannabis, more than the euphoria: its therapeutic use in drug-resistant epilepsy. |
2020-09-28 |
2023-08-13 |
Not clear |
| Keri-Ann R Buchanan-Peart, Geraldine I Oribhabor, Rhutuja V Khokale, Maxine L Nelson, Ivan Cancarevi. Cannabis, More Than the Euphoria: Its Therapeutic Use in Drug-Resistant Epilepsy. Cureus. vol 12. issue 7. 2020-09-28. PMID:32832296. |
this review seeks to analyze data presented on the pharmacology, safety, and efficacy of cannabis use in patients with drug-resistant epilepsy (dre) and to propose any future recommendations regarding its use. |
2020-09-28 |
2023-08-13 |
Not clear |
| Keri-Ann R Buchanan-Peart, Geraldine I Oribhabor, Rhutuja V Khokale, Maxine L Nelson, Ivan Cancarevi. Cannabis, More Than the Euphoria: Its Therapeutic Use in Drug-Resistant Epilepsy. Cureus. vol 12. issue 7. 2020-09-28. PMID:32832296. |
pubmed was used to retrieve all published studies and articles which evaluated the use of cannabis in epilepsy. |
2020-09-28 |
2023-08-13 |
Not clear |
| Renad Abu-Sawwa, Brielle Scutt, Yong Par. Emerging Use of Epidiolex (Cannabidiol) in Epilepsy. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. vol 25. issue 6. 2020-09-28. PMID:32839652. |
emerging use of epidiolex (cannabidiol) in epilepsy. |
2020-09-28 |
2023-08-13 |
Not clear |
| Gianluca D'Onofrio, Mathieu Kuchenbuch, Caroline Hachon-Le Camus, Béatrice Desnous, Véronique Staath, Sylvia Napuri, Dorothée Ville, Jean-Michel Pedespan, Anne Lépine, Claude Cances, Anne de Saint-Martin, Théo Teng, Nicole Chemaly, Mathieu Milh, Nathalie Villeneuve, Rima Nabbou. Slow Titration of Cannabidiol Add-On in Drug-Resistant Epilepsies Can Improve Safety With Maintained Efficacy in an Open-Label Study. Frontiers in neurology. vol 11. 2020-09-28. PMID:32903409. |
slow titration of cannabidiol add-on in drug-resistant epilepsies can improve safety with maintained efficacy in an open-label study. |
2020-09-28 |
2023-08-13 |
Not clear |
| Abbie D Leino, Chie Emoto, Tsuyoshi Fukuda, Michael Privitera, Alexander A Vinks, Rita R Allowa. Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. vol 19. issue 10. 2020-09-04. PMID:31012522. |
cannabidiol (cbd), a major purified nonpsychoactive component of cannabis with anticonvulsant properties, was approved by the u.s. food and drug administration (fda) in june 2018 as an adjuvant treatment for refractory epilepsy (epidiolex; gw pharmaceuticals). |
2020-09-04 |
2023-08-13 |
human |
| James W Wheless, Dennis Dlugos, Ian Miller, D Alexander Oh, Neha Parikh, Steven Phillips, J Ben Renfroe, Colin M Roberts, Isra Saeed, Steven P Sparagana, Jin Yu, Maria Roberta Cili. Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy. CNS drugs. vol 33. issue 6. 2020-08-28. PMID:31049885. |
pharmacokinetics and tolerability of multiple doses of pharmaceutical-grade synthetic cannabidiol in pediatric patients with treatment-resistant epilepsy. |
2020-08-28 |
2023-08-13 |
Not clear |